Topical Nicotinamide in Treatment of DLE
Efficacy and Safety of Topical Nicotinamide in Treatment of Discoid Lupus Erythematosus
Sponsor: Al-Azhar University
This EARLY_PHASE1 trial investigates Discoid Lupus Erythematosus and is currently completed. Al-Azhar University leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Nov 2022 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Recruiting → Completed · Phase: NA → EARLY_PHASE1
-
Jun 2022 — Nov 2022 [monthly]
Recruiting NA
First recorded
Mar 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Al-Azhar University
For direct contact, visit the study record on ClinicalTrials.gov .